Pictet Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65M | Buy |
1,404,444
+8,354
| +0.6% | +$387K | 0.07% | 272 |
|
|
2025
Q1 | $85.1M | Buy |
1,396,090
+100,200
| +8% | +$6.11M | 0.09% | 223 |
|
|
2024
Q4 | $73.3M | Buy |
1,295,890
+161,739
| +14% | +$9.15M | 0.08% | 246 |
|
|
2024
Q3 | $58.7M | Buy |
1,134,151
+41,799
| +4% | +$2.16M | 0.06% | 268 |
|
|
2024
Q2 | $45.4M | Buy |
1,092,352
+42,253
| +4% | +$1.75M | 0.05% | 301 |
|
|
2024
Q1 | $56.9M | Sell |
1,050,099
-54,303
| -5% | -$2.94M | 0.06% | 284 |
|
|
2023
Q4 | $56.7M | Buy |
1,104,402
+15,320
| +1% | +$786K | 0.06% | 280 |
|
|
2023
Q3 | $63.2M | Buy |
+1,089,082
| New | +$63.2M | 0.08% | 254 |
|